• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMylan

Mylan

Page 5 of 6
Senator Amy Klobuchar, D-MN, listens to
HealthLawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By Sy MukherjeeAugust 23, 2016
Amid debate on drug prices, California leads way on cost controls
HealthHow Mylan Got Away With Its Enormous Price Hike for the EpiPen
By Sy MukherjeeAugust 22, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
HealthHow Mylan Is Taking On One of the World’s Top Breast Cancer Drugs
By Sy MukherjeeJune 5, 2016
Mylan NV Chief Executive Officer Heather Bresch Interview
FinanceHere’s Why Mylan’s Stock Plunged
By Jen WiecznerFebruary 11, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan Reaches $7.2 Billion Deal for Meda
By Laura LorenzettiFebruary 10, 2016
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
FinanceWhy Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
LeadershipMylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Mylan's Heather Bresch at the 2015 MPW Summit.
MPWMylan CEO Heather Bresch: We needed tax inversion in order to grow
By Jen WiecznerOctober 14, 2015
Perrigo CEO Joe Papa, right, at a charity event in 2013.
FinanceWhy this pharma CEO bought his arch-rival’s stock
By Jen WiecznerSeptember 18, 2015
Blurred governance: Mylan’s illusions vs. BofA’s realities
LeadershipBlurred governance: Mylan’s illusions vs. BofA’s realities
By Jeffrey SonnenfeldSeptember 15, 2015
Heather Bresch CEO of Mylan a global pharmaceutical company
MPWWhy Wall Street loves to hate Mylan’s CEO
By Jen WiecznerSeptember 11, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
FinanceThis drug-industry deal would be the largest hostile takeover in history
By Jen WiecznerSeptember 8, 2015
Google/E.U. and Walmart’s holiday sales — 5 things to know today
FeaturesGoogle/E.U. and Walmart’s holiday sales — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithAugust 28, 2015
Trader watches the screen at his terminal on the floor of the New York Stock Exchange in New York
FeaturesStocks, economic growth, and a Fed conference — 5 things to know this week
By Tom Huddleston Jr.August 23, 2015
1
  • 2
  • 3
  • 4
  • 5
  • 6
6
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Big Tech
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?placeholder alt text
By Alexei OreskovicApril 29, 2026
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointeeplaceholder alt text
By Eva RoytburgApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.